Loading…

Effect of murine recombinant interleukin‐5 on the cell population in guinea‐pig airways

1 An intratracheal injection of murine recombinant interleukin 5 (mrIL‐5, 2–15 μg/0.25 ml/animal) induced a dose‐dependent increase in the number of macrophages, eosinophils, neutrophils and epithelial cells in the bronchoalveolar lavage fluid (BALF) of guinea‐pigs 24 h after administration. Bovine...

Full description

Saved in:
Bibliographic Details
Published in:British journal of pharmacology 1992-01, Vol.105 (1), p.19-22
Main Authors: Iwama, T., Nagai, H., Suda, H., Tsuruoka, N., Koda, A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c6044-42ab88a9569307a75991d9a70a6494cd3536e5f78992314d46bdc26c59eea1123
cites cdi_FETCH-LOGICAL-c6044-42ab88a9569307a75991d9a70a6494cd3536e5f78992314d46bdc26c59eea1123
container_end_page 22
container_issue 1
container_start_page 19
container_title British journal of pharmacology
container_volume 105
creator Iwama, T.
Nagai, H.
Suda, H.
Tsuruoka, N.
Koda, A.
description 1 An intratracheal injection of murine recombinant interleukin 5 (mrIL‐5, 2–15 μg/0.25 ml/animal) induced a dose‐dependent increase in the number of macrophages, eosinophils, neutrophils and epithelial cells in the bronchoalveolar lavage fluid (BALF) of guinea‐pigs 24 h after administration. Bovine serum albumin (15 μg/0.25 ml/animal), used as a reference material, did not cause any change of this type. 2 The intratracheal administration of mrIL‐5 at a dose of 15 μg showed a tendency to increase the number of these pulmonary inflammatory cells and epithelial cells in the BALF at 12 h with a significant increase observed at 24 h. 3 Prednisolone (20 mg kg−1, i.p.) inhibited the mrIL‐5‐induced increase in macrophages, eosinophils, neutrophils and epithelial cells. Ketotifen (2 mg kg−1, i.p.) reduced the mrIL‐5‐induced increase in the eosinophil, neutrophil and epithelial cell populations. The simultaneous injection of 2% disodium cromoglycate (DSCG) into the trachea prevented the mrIL‐5‐induced increase in the number of airway epithelial cells, without affecting changes in the other inflammatory leukocytes. 4 These results suggest that mrIL‐5 is a potent inducer of lung inflammation, in terms of increased inflammatory leukocytes and epithelial cells in guinea‐pig BALF. Prednisolone, DSCG and ketotifen are effective against mrIL‐5‐induced pulmonary inflammation, especially the desquamation of bronchial epithelial cells.
doi_str_mv 10.1111/j.1476-5381.1992.tb14204.x
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1908616</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72979342</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6044-42ab88a9569307a75991d9a70a6494cd3536e5f78992314d46bdc26c59eea1123</originalsourceid><addsrcrecordid>eNqVkcFu1DAURS0EKkPhE5AshNgl-CW2E7NAQFUoUiVYwIqF9eI4Uw-JM9gJ7ez4BL6RL8FhRgOsEN7Y8j3v6l1dQh4ByyGdp5sceCUzUdaQg1JFPjXAC8bzm1tkdZRukxVjrMoA6vouuRfjhrEkVuKEnIBQUtawIp_Ou86aiY4dHebgvKXBmnFonEc_UecnG3o7f3b-x7fvgo6eTleWGtv3dDtu5x4nl_6cp-s5zWKCtm5N0YVr3MX75E6HfbQPDvcp-fj6_MPZRXb57s3bs5eXmZGM84wX2NQ1KiFVySqshFLQKqwYSq64aUtRSiu6qk5JS-Atl01rCmmEshYBivKUPN_7budmsK2xfgrY621wA4adHtHpvxXvrvR6_KpBsVqCTAZPDgZh_DLbOOnBxSUkejvOUVeFqlTJi3-CILlUUKgEPtuDJowxBtsdtwGmlw71Ri9F6aUovXSoDx3qmzT88M88v0f3pSX98UHHaLDvAnrj4hETAIJBmbAXe-za9Xb3HwvoV-8vfj3Ln-BKvAY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16469129</pqid></control><display><type>article</type><title>Effect of murine recombinant interleukin‐5 on the cell population in guinea‐pig airways</title><source>PubMed Central Free</source><creator>Iwama, T. ; Nagai, H. ; Suda, H. ; Tsuruoka, N. ; Koda, A.</creator><creatorcontrib>Iwama, T. ; Nagai, H. ; Suda, H. ; Tsuruoka, N. ; Koda, A.</creatorcontrib><description>1 An intratracheal injection of murine recombinant interleukin 5 (mrIL‐5, 2–15 μg/0.25 ml/animal) induced a dose‐dependent increase in the number of macrophages, eosinophils, neutrophils and epithelial cells in the bronchoalveolar lavage fluid (BALF) of guinea‐pigs 24 h after administration. Bovine serum albumin (15 μg/0.25 ml/animal), used as a reference material, did not cause any change of this type. 2 The intratracheal administration of mrIL‐5 at a dose of 15 μg showed a tendency to increase the number of these pulmonary inflammatory cells and epithelial cells in the BALF at 12 h with a significant increase observed at 24 h. 3 Prednisolone (20 mg kg−1, i.p.) inhibited the mrIL‐5‐induced increase in macrophages, eosinophils, neutrophils and epithelial cells. Ketotifen (2 mg kg−1, i.p.) reduced the mrIL‐5‐induced increase in the eosinophil, neutrophil and epithelial cell populations. The simultaneous injection of 2% disodium cromoglycate (DSCG) into the trachea prevented the mrIL‐5‐induced increase in the number of airway epithelial cells, without affecting changes in the other inflammatory leukocytes. 4 These results suggest that mrIL‐5 is a potent inducer of lung inflammation, in terms of increased inflammatory leukocytes and epithelial cells in guinea‐pig BALF. Prednisolone, DSCG and ketotifen are effective against mrIL‐5‐induced pulmonary inflammation, especially the desquamation of bronchial epithelial cells.</description><identifier>ISSN: 0007-1188</identifier><identifier>EISSN: 1476-5381</identifier><identifier>DOI: 10.1111/j.1476-5381.1992.tb14204.x</identifier><identifier>PMID: 1596681</identifier><identifier>CODEN: BJPCBM</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>airway cell populations ; airway inflammation ; Animals ; anti‐asthmatic drugs ; Asthma - drug therapy ; Asthma - pathology ; Biological and medical sciences ; Bronchoalveolar Lavage Fluid - cytology ; Cell Count - drug effects ; Epithelial Cells ; Epithelium - drug effects ; Guinea Pigs ; Interleukin-5 - pharmacology ; Interleukin‐5 (IL‐5) ; Leukocyte Count - drug effects ; Medical sciences ; Mice ; Pharmacology. Drug treatments ; Recombinant Proteins - pharmacology ; Respiratory system ; Trachea - cytology ; Trachea - drug effects</subject><ispartof>British journal of pharmacology, 1992-01, Vol.105 (1), p.19-22</ispartof><rights>1992 British Pharmacological Society</rights><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6044-42ab88a9569307a75991d9a70a6494cd3536e5f78992314d46bdc26c59eea1123</citedby><cites>FETCH-LOGICAL-c6044-42ab88a9569307a75991d9a70a6494cd3536e5f78992314d46bdc26c59eea1123</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1908616/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1908616/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,4024,27923,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5115013$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1596681$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Iwama, T.</creatorcontrib><creatorcontrib>Nagai, H.</creatorcontrib><creatorcontrib>Suda, H.</creatorcontrib><creatorcontrib>Tsuruoka, N.</creatorcontrib><creatorcontrib>Koda, A.</creatorcontrib><title>Effect of murine recombinant interleukin‐5 on the cell population in guinea‐pig airways</title><title>British journal of pharmacology</title><addtitle>Br J Pharmacol</addtitle><description>1 An intratracheal injection of murine recombinant interleukin 5 (mrIL‐5, 2–15 μg/0.25 ml/animal) induced a dose‐dependent increase in the number of macrophages, eosinophils, neutrophils and epithelial cells in the bronchoalveolar lavage fluid (BALF) of guinea‐pigs 24 h after administration. Bovine serum albumin (15 μg/0.25 ml/animal), used as a reference material, did not cause any change of this type. 2 The intratracheal administration of mrIL‐5 at a dose of 15 μg showed a tendency to increase the number of these pulmonary inflammatory cells and epithelial cells in the BALF at 12 h with a significant increase observed at 24 h. 3 Prednisolone (20 mg kg−1, i.p.) inhibited the mrIL‐5‐induced increase in macrophages, eosinophils, neutrophils and epithelial cells. Ketotifen (2 mg kg−1, i.p.) reduced the mrIL‐5‐induced increase in the eosinophil, neutrophil and epithelial cell populations. The simultaneous injection of 2% disodium cromoglycate (DSCG) into the trachea prevented the mrIL‐5‐induced increase in the number of airway epithelial cells, without affecting changes in the other inflammatory leukocytes. 4 These results suggest that mrIL‐5 is a potent inducer of lung inflammation, in terms of increased inflammatory leukocytes and epithelial cells in guinea‐pig BALF. Prednisolone, DSCG and ketotifen are effective against mrIL‐5‐induced pulmonary inflammation, especially the desquamation of bronchial epithelial cells.</description><subject>airway cell populations</subject><subject>airway inflammation</subject><subject>Animals</subject><subject>anti‐asthmatic drugs</subject><subject>Asthma - drug therapy</subject><subject>Asthma - pathology</subject><subject>Biological and medical sciences</subject><subject>Bronchoalveolar Lavage Fluid - cytology</subject><subject>Cell Count - drug effects</subject><subject>Epithelial Cells</subject><subject>Epithelium - drug effects</subject><subject>Guinea Pigs</subject><subject>Interleukin-5 - pharmacology</subject><subject>Interleukin‐5 (IL‐5)</subject><subject>Leukocyte Count - drug effects</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Pharmacology. Drug treatments</subject><subject>Recombinant Proteins - pharmacology</subject><subject>Respiratory system</subject><subject>Trachea - cytology</subject><subject>Trachea - drug effects</subject><issn>0007-1188</issn><issn>1476-5381</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><recordid>eNqVkcFu1DAURS0EKkPhE5AshNgl-CW2E7NAQFUoUiVYwIqF9eI4Uw-JM9gJ7ez4BL6RL8FhRgOsEN7Y8j3v6l1dQh4ByyGdp5sceCUzUdaQg1JFPjXAC8bzm1tkdZRukxVjrMoA6vouuRfjhrEkVuKEnIBQUtawIp_Ou86aiY4dHebgvKXBmnFonEc_UecnG3o7f3b-x7fvgo6eTleWGtv3dDtu5x4nl_6cp-s5zWKCtm5N0YVr3MX75E6HfbQPDvcp-fj6_MPZRXb57s3bs5eXmZGM84wX2NQ1KiFVySqshFLQKqwYSq64aUtRSiu6qk5JS-Atl01rCmmEshYBivKUPN_7budmsK2xfgrY621wA4adHtHpvxXvrvR6_KpBsVqCTAZPDgZh_DLbOOnBxSUkejvOUVeFqlTJi3-CILlUUKgEPtuDJowxBtsdtwGmlw71Ri9F6aUovXSoDx3qmzT88M88v0f3pSX98UHHaLDvAnrj4hETAIJBmbAXe-za9Xb3HwvoV-8vfj3Ln-BKvAY</recordid><startdate>199201</startdate><enddate>199201</enddate><creator>Iwama, T.</creator><creator>Nagai, H.</creator><creator>Suda, H.</creator><creator>Tsuruoka, N.</creator><creator>Koda, A.</creator><general>Blackwell Publishing Ltd</general><general>Nature Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>199201</creationdate><title>Effect of murine recombinant interleukin‐5 on the cell population in guinea‐pig airways</title><author>Iwama, T. ; Nagai, H. ; Suda, H. ; Tsuruoka, N. ; Koda, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6044-42ab88a9569307a75991d9a70a6494cd3536e5f78992314d46bdc26c59eea1123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>airway cell populations</topic><topic>airway inflammation</topic><topic>Animals</topic><topic>anti‐asthmatic drugs</topic><topic>Asthma - drug therapy</topic><topic>Asthma - pathology</topic><topic>Biological and medical sciences</topic><topic>Bronchoalveolar Lavage Fluid - cytology</topic><topic>Cell Count - drug effects</topic><topic>Epithelial Cells</topic><topic>Epithelium - drug effects</topic><topic>Guinea Pigs</topic><topic>Interleukin-5 - pharmacology</topic><topic>Interleukin‐5 (IL‐5)</topic><topic>Leukocyte Count - drug effects</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Pharmacology. Drug treatments</topic><topic>Recombinant Proteins - pharmacology</topic><topic>Respiratory system</topic><topic>Trachea - cytology</topic><topic>Trachea - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Iwama, T.</creatorcontrib><creatorcontrib>Nagai, H.</creatorcontrib><creatorcontrib>Suda, H.</creatorcontrib><creatorcontrib>Tsuruoka, N.</creatorcontrib><creatorcontrib>Koda, A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Iwama, T.</au><au>Nagai, H.</au><au>Suda, H.</au><au>Tsuruoka, N.</au><au>Koda, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of murine recombinant interleukin‐5 on the cell population in guinea‐pig airways</atitle><jtitle>British journal of pharmacology</jtitle><addtitle>Br J Pharmacol</addtitle><date>1992-01</date><risdate>1992</risdate><volume>105</volume><issue>1</issue><spage>19</spage><epage>22</epage><pages>19-22</pages><issn>0007-1188</issn><eissn>1476-5381</eissn><coden>BJPCBM</coden><abstract>1 An intratracheal injection of murine recombinant interleukin 5 (mrIL‐5, 2–15 μg/0.25 ml/animal) induced a dose‐dependent increase in the number of macrophages, eosinophils, neutrophils and epithelial cells in the bronchoalveolar lavage fluid (BALF) of guinea‐pigs 24 h after administration. Bovine serum albumin (15 μg/0.25 ml/animal), used as a reference material, did not cause any change of this type. 2 The intratracheal administration of mrIL‐5 at a dose of 15 μg showed a tendency to increase the number of these pulmonary inflammatory cells and epithelial cells in the BALF at 12 h with a significant increase observed at 24 h. 3 Prednisolone (20 mg kg−1, i.p.) inhibited the mrIL‐5‐induced increase in macrophages, eosinophils, neutrophils and epithelial cells. Ketotifen (2 mg kg−1, i.p.) reduced the mrIL‐5‐induced increase in the eosinophil, neutrophil and epithelial cell populations. The simultaneous injection of 2% disodium cromoglycate (DSCG) into the trachea prevented the mrIL‐5‐induced increase in the number of airway epithelial cells, without affecting changes in the other inflammatory leukocytes. 4 These results suggest that mrIL‐5 is a potent inducer of lung inflammation, in terms of increased inflammatory leukocytes and epithelial cells in guinea‐pig BALF. Prednisolone, DSCG and ketotifen are effective against mrIL‐5‐induced pulmonary inflammation, especially the desquamation of bronchial epithelial cells.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>1596681</pmid><doi>10.1111/j.1476-5381.1992.tb14204.x</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-1188
ispartof British journal of pharmacology, 1992-01, Vol.105 (1), p.19-22
issn 0007-1188
1476-5381
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1908616
source PubMed Central Free
subjects airway cell populations
airway inflammation
Animals
anti‐asthmatic drugs
Asthma - drug therapy
Asthma - pathology
Biological and medical sciences
Bronchoalveolar Lavage Fluid - cytology
Cell Count - drug effects
Epithelial Cells
Epithelium - drug effects
Guinea Pigs
Interleukin-5 - pharmacology
Interleukin‐5 (IL‐5)
Leukocyte Count - drug effects
Medical sciences
Mice
Pharmacology. Drug treatments
Recombinant Proteins - pharmacology
Respiratory system
Trachea - cytology
Trachea - drug effects
title Effect of murine recombinant interleukin‐5 on the cell population in guinea‐pig airways
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A38%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20murine%20recombinant%20interleukin%E2%80%905%20on%20the%20cell%20population%20in%20guinea%E2%80%90pig%20airways&rft.jtitle=British%20journal%20of%20pharmacology&rft.au=Iwama,%20T.&rft.date=1992-01&rft.volume=105&rft.issue=1&rft.spage=19&rft.epage=22&rft.pages=19-22&rft.issn=0007-1188&rft.eissn=1476-5381&rft.coden=BJPCBM&rft_id=info:doi/10.1111/j.1476-5381.1992.tb14204.x&rft_dat=%3Cproquest_pubme%3E72979342%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c6044-42ab88a9569307a75991d9a70a6494cd3536e5f78992314d46bdc26c59eea1123%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16469129&rft_id=info:pmid/1596681&rfr_iscdi=true